Like a delivery driver navigating crowded city streets, a gene-therapy-toting lipid nanoparticle faces a gauntlet of potential detours on its journey toward a cell's nucleus. First, there's entering ...

For patients with blood cancers like leukemia and lymphoma, the immunotherapy known as CAR-T cell therapy can be lifesaving.

Startups and Big Ag are using Crispr gene editing to create crops that taste better and grow on a hotter planet. But will they find a market?

The CRISPR therapy, SNIPR001, was administered following a single-patient emergency investigational new drug application.

CRISPR Therapeutics (CRSP) remains a Strong Buy, supported by robust CASGEVY sales growth and pipeline expansion.

The next six months may be decisive for the biotech.

Bacteria-killing phage viruses souped up with DNA-destroying CRISPR appear to have helped clear up a very serious infection caused by antibiotic-resistant E. coli ...

The CEO spoke with BioPharma Dive about convincing investors to buy into the first gene editing IPO in more than two years.

Now, there is renewed hope that allergies won't get in the way of pet ownership.

Like a delivery driver navigating crowded city streets, a gene-therapy-toting lipid nanoparticle faces a gauntlet of potential detours on its journey toward a cell's nucleus. First, there's entering ...

The main function of CRISPR-Cas systems is to defend bacteria against various threats, including viruses called ...

Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...